BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thylur RP, Roy SK, Shrivastava A, LaVeist TA, Shankar S, Srivastava RK. Assessment of risk factors, and racial and ethnic differences in hepatocellular carcinoma. JGH Open 2020;4:351-9. [PMID: 32514436 DOI: 10.1002/jgh3.12336] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Noverati N, Bashir-Hamidu R, Halegoua-DeMarzio D, Hann HW. Hepatitis B Virus-Associated Hepatocellular Carcinoma and Chronic Stress. Int J Mol Sci 2022;23:3917. [PMID: 35409275 DOI: 10.3390/ijms23073917] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Abdalla A, Murali C, Amin A. Safranal Inhibits Angiogenesis via Targeting HIF-1α/VEGF Machinery: In Vitro and Ex Vivo Insights. Front Oncol 2021;11:789172. [PMID: 35211395 DOI: 10.3389/fonc.2021.789172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
3 Lam BQ, Srivastava R, Morvant J, Shankar S, Srivastava RK. Association of Diabetes Mellitus and Alcohol Abuse with Cancer: Molecular Mechanisms and Clinical Significance. Cells 2021;10:3077. [PMID: 34831299 DOI: 10.3390/cells10113077] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Zhang X, Guan L, Tian H, Zeng Z, Chen J, Huang D, Sun J, Guo J, Cui H, Li Y. Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma. Front Oncol 2021;11:686962. [PMID: 34568017 DOI: 10.3389/fonc.2021.686962] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Zheng G, Sundquist K, Sundquist J, Chen T, Försti A, Hemminki A, Liska V, Hemminki K. Second Primary Cancers After Liver, Gallbladder and Bile Duct Cancers, and These Cancers as Second Primary Cancers. Clin Epidemiol 2021;13:683-91. [PMID: 34377034 DOI: 10.2147/CLEP.S318737] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Wang J, Liu W, Li JC, Li M, Li B, Zhu R. Hepcidin Downregulation Correlates With Disease Aggressiveness And Immune Infiltration in Liver Cancers. Front Oncol 2021;11:714756. [PMID: 34277457 DOI: 10.3389/fonc.2021.714756] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Kunadirek P, Chuaypen N, Jenjaroenpun P, Wongsurawat T, Pinjaroen N, Sirichindakul P, Nookaew I, Tangkijvanich P. Cell-Free DNA Analysis by Whole-Exome Sequencing for Hepatocellular Carcinoma: A Pilot Study in Thailand. Cancers (Basel) 2021;13:2229. [PMID: 34066484 DOI: 10.3390/cancers13092229] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Rice DR, Hyer JM, Diaz A, Pawlik TM. End-of-Life Hospice Use and Medicare Expenditures Among Patients Dying of Hepatocellular Carcinoma. Ann Surg Oncol 2021;28:5414-22. [PMID: 33528708 DOI: 10.1245/s10434-021-09606-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Rice DR, Pawlik TM. ASO Author Reflections: Optimizing End-of-Life Care for Patients Dying from Hepatocellular Carcinoma. Ann Surg Oncol 2021;28:5423-4. [PMID: 33521904 DOI: 10.1245/s10434-021-09609-4] [Reference Citation Analysis]
10 Arif D, Mettler T, Adeyi OA. Mimics of hepatocellular carcinoma: a review and an approach to avoiding histopathological diagnostic missteps. Hum Pathol 2021;112:116-27. [PMID: 33346018 DOI: 10.1016/j.humpath.2020.12.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Suresh D, Srinivas AN, Kumar DP. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease. Front Oncol 2020;10:601710. [PMID: 33330100 DOI: 10.3389/fonc.2020.601710] [Cited by in Crossref: 10] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]